drugset / Trial / NCT04951817
68Ga-PSMA PET/CT for Ra223 Assessment
NaSingle-groupOpen-labelDiagnostic
Summary
Primary objective: i.The primary objective is to compare the diagnostic positivity in progression of 68Ga-PSMA PET and Bone scan. Secondary objectives: i.The correlation between PET osseous tumor burden index and Alk-P level ii.The correlation between PET osseous tumor burden index and PSA level
Timeline
- Start
- 2022-03-02
- Primary completion
- 2025-08-31
- Completion
- 2025-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ga-68 PSMA ligand | Diagnostic / imaging agent | 2 unknown | Intravenous |
| Subject | Ga-68 PSMA ligand | Diagnostic / imaging agent | 5 unknown | Intravenous |